UncategorizedRejuve.AI partners with FLT to advance personalized longevity Empower Meds / October 17, 2025
UncategorizedOcuSciences gains EU clearance for retinal imaging device – Longevity.Technology Empower Meds / October 17, 2025
UncategorizedBexorg raises $42.5 M to advance AI-integrated human brain drug platform – Longevity.Technology Empower Meds / October 17, 2025
UncategorizedBellaMia secures FDA clearance for Botticelli skin rejuvenation system – Longevity.Technology Empower Meds / October 17, 2025
UncategorizedCelularity publishes phase 2 results for PDA-002 in diabetic foot ulcers – Longevity.Technology Empower Meds / October 17, 2025
UncategorizedTransforming CNS drug discovery using ‘reactivated’ human brains Empower Meds / October 16, 2025
UncategorizedFunction Health honored by Goldman Sachs at entrepreneurship summit – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedTelomir reveals preclinical results for Telomir-1 in cell and animal models – Longevity.Technology Empower Meds / October 16, 2025
